Proposed Drug definition

Proposed Drug means the drug or drugs that Medco, in its Drug Interchange Solicitation, proposes to substitute for a Currently Prescribed Drug.
Sample 1Sample 2Sample 3
Proposed Drug means the drug or drugs that Medco, in its Drug Interchange
Sample 1
Proposed Drug means the drug or drugs that Caremark, in its Drug Interchange Solicitation program, proposes to interchange for an Originally Prescribed Drug.
Sample 1Sample 2

Examples of Proposed Drug in a sentence

  • Upon cancellation, if Medco has not yet dispensed the Proposed Drug, Medco, upon approval of the Prescriber, shall dispense the Currently Prescribed Drug.

  • Unless otherwise provided by contract with a Client Plan, Medco shall also bear the expense of shipping the Proposed Drug back to Medco (either by offset or by reversing and crediting the initial co-pay).

  • Disclose any material differences, as determined by the Medco P&T Committee, between the Currently Prescribed Drug and the Proposed Drug with respect to side effects or potential effects on patient health and safety.

  • Make any Drug Interchange Solicitation where the Net Drug Cost of the Proposed Drug exceeds that of the Currently Prescribed Drug.

  • With respect to all Drug Interchange Solicitations and communications related to Drug Interchanges, Medco shall not misrepresent the role of Medco’s P&T Committee in initiating, reviewing, approving or endorsing a Proposed Drug Interchange or Interchange Solicitation.

  • Evaluating Motivational Factors Involved at Different Stages in an IS Outsourcing Decision Process.

  • The optimized interlayer distances for the slabs are summarized in Table 2.

  • Mike calculated that the total cost for the addition would be 300 bags of rice.

  • If Medco has already dispensed the Proposed Drug, Medco shall obtain a prescription for, and dispense the Currently Prescribed Drug, and Medco shall charge the Patient only one co-pay and shipping and handling fees (so that a proposed but reversed Interchange will not increase Patient costs beyond the costs had Medco dispensed the Currently Prescribed Drug).

  • Our yeast14 cultures may have included more than one species but we found little quantitative15 differences between the different cultures.

Related to Proposed Drug

  • New drug means: (i) any drug, except a new animal drug or an animal feed bearing or containing

  • New Drug Application means a New Drug Application filed with the FDA in accordance with Applicable Law.

  • FDCA shall have the meaning ascribed to such term in Section 3.1(hh).

  • FFDCA means the United States Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 301 et seq., as amended from time to time, together with any rules, regulations and requirements promulgated thereunder (including all additions, supplements, extensions, and modifications thereto).

  • Legend drug or "prescription drug" means any drug or device that has been determined to be unsafe for self- medication or any drug or device that bears or is required to bear the legend:

  • Generic Drug means any Prescription Drug approved by the FDA that has the same bio-equivalency as a specific Brand Name Drug.

  • Covered drug means any prescription drug that:

  • Legend drugs means any drugs which are required by state

  • Biosimilar Product means, with respect to a Licensed Product in any country, any biosimilar product sold by a Third Party not authorized by or on behalf of Celgene, its Affiliates or Sublicensees, (a) that is a biosimilar biological product, as defined in 21 USC 379j-51 (or any successor or replacement thereof), a similar biological medicinal product, as defined in Annex I to Directive 2001/83/EC (or any successor or replacement thereof), or any similar biosimilar or generic product under the Laws of any country or jurisdiction, or (b) regarding which Regulatory Approval is obtained by referencing Regulatory Data of such Licensed Product.

  • controlled drug means an article or substance prescribed under a regulation to be a controlled drug.

  • FDA means the United States Food and Drug Administration.

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Drug Approval Application means, with respect to a Licensed Product in the Territory, an application for Regulatory Approval for such product in a country in the Territory. For purposes of clarity, Drug Approval Application shall include, without limitation, (a) an NDA or BLA (for U.S.) or MAA (for Europe); (b) a counterpart of an NDA, BLA or MAA in any country or region in the Territory; and (c) all supplements (including supplemental applications such as sNDAs) and amendments to the foregoing.

  • FDA Act means the U.S. Federal Food, Drug and Cosmetic Act, as amended, and the rules and regulations promulgated thereunder.

  • Edible cannabis product means cannabis product that is intended to be used, in whole or in part, for human consumption, including, but not limited to, chewing gum, but excluding products set forth in Division 15 (commencing with Section 32501) of the Food and Agricultural Code. An edible cannabis product is not considered food, as defined by Section 109935 of the Health and Safety Code, or a drug, as defined by Section 109925 of the Health and Safety Code.

  • low protein modified food product means a food product that is specially formulated to have less than one gram of protein per serving and is intended to be used under the direction of a Practitioner for the dietary treatment of an inherited metabolic disease, but does not include a natural food that is naturally low in protein; and

  • Approved clinical trial means a phase I, phase II, phase III, or phase IV clinical trial that is conducted in relation to the prevention, detection, or treatment of cancer or other life-threatening disease or Condition and is described in any of the following:

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Drug Application means a new drug application, an abbreviated drug application, or a product license application for any Product, as appropriate, as those terms are defined in the FDCA.

  • Phase III Clinical Trial means a large, controlled or uncontrolled Clinical Study that would satisfy the requirements of 21 CFR 312.21(c), intended to gather the additional information about effectiveness and safety that is needed to evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • FD&C Act means the U.S. Federal Food, Drug and Cosmetic Act, as amended, and the regulations promulgated thereunder.

  • Drug addiction means a disease characterized by a

  • FDA Approval means with respect to the Product, a Regulatory Approval by the FDA for the commercial use of the Product in the United States.

  • Prescription drug order means a lawful order of a practitioner for a drug or device for a specific patient that is communicated to a pharmacist.

  • Anti-Static Product means a product that is labeled to eliminate, prevent, or inhibit the accumulation of static electricity. “Anti-Static Product” does not include “Electronic Cleaner,” “Floor Polish or Wax,” “Floor Coating,” and products that meet the definition of “Aerosol Coating Product” or “Architectural Coating.”